Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $41.15 USD
Change Today +0.52 / 1.28%
Volume 544.0K
IPXL On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Carole S. Ben-Maimon M.D.

AgeTotal Calculated CompensationThis person is connected to 12 board members in 1 different organizations across 4 different industries.

See Board Relationships
56$3,427,139
As of Fiscal Year 2014

Background*

Dr. Carole S. Ben-Maimon, M.D. served as the President of Global Pharmaceuticals Division at Impax Laboratories Inc. from September 6, 2011 to November 3, 2014. Dr. Ben-Maimon served as the President and Chief Executive Officer of Alita Pharmaceuticals, Inc. Prior to founding Alita Pharmaceuticals, Dr. Ben-Maimon served as the President & Chief Operating Officer of Duramed Research, the proprietary products research and development subsidiary of Barr Pharmaceuticals, ...

Read Full Background

Corporate Headquarters*

30831 Huntwood Avenue
Hayward, California 94544

United States

Phone: 510-476-2000
Fax: 510-240-6096

Board Members Memberships*

Director

Education*

BA
The University of Pennsylvania
Unknown/Other Education
Thomas Jefferson University School Of Medicine

Other Affiliations*

Annual Compensation*

Salary$458,022
Total Annual Compensation$458,022

Stock Options*

Restricted Stock Awards$580,520
All Other Compensation$1,351,249
Exercisable Options110,858
Exercisable Options Value$1,335,113
Total Value of Options$1,335,112
Total Number of Options110,858

Total Compensation*

Total Annual Cash Compensation$2,262,519
Total Short Term Compensation$458,022
Other Long Term Compensation$1,931,769
Total Calculated Compensation$3,427,139
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IPXL:US $41.15 USD +0.52

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jean Madar Co-Founder,Chairman, Chief Executive Officer and Director General of Inter Parfums S A
Inter Parfums Inc.
$630.0K
Jeffrey Siegel Chairman, Chief Executive Officer and Member of Strategic Planning Committee
Lifetime Brands, Inc.
$1.0M
Hari Shankar Bhartia B.TechCo-Chairman, Managing Director, Chairman of Corporate Governance Committee, Member of Finance Committee, Member of Sustainability & CSR Committee and Member of Fund Raising Committee
Jubilant Life Sciences Limited
--
Daniel J. Abdun-Nabi Chief Executive Officer, President, Director, Member of Strategic Operations Committee and Member of Pricing Committee
Emergent BioSolutions, Inc.
$1.2M
Allan Oberman Chief Executive Officer and Director
Sagent Pharmaceuticals, Inc.
--
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMPAX LABORATORIES INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.